Skip to content

Drug interactions

Solifenacin + Tucatinib

Severity: Moderate

Solifenacin and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A4, the main enzyme clearing solifenacin, so solifenacin exposure can rise. This may increase anticholinergic effects such as dry mouth, constipation, urinary retention, blurred vision and QT prolongation risk.

What this interaction means in plain words

Solifenacin and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Solifenacin belongs to Genitourinary; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibition of CYP3A4-mediated solifenacin metabolism increases solifenacin plasma concentrations.

What to do

Monitor for anticholinergic adverse effects and limit solifenacin to 5 mg daily if tucatinib is co-prescribed; consider an alternative agent in patients with QT risk.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Solifenacin and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Solifenacin with Tucatinib?

MediHelp rates the interaction as moderate. Solifenacin and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits CYP3A4, the main enzyme clearing solifenacin, so solifenacin exposure can rise. This may increase anticholinergic effects such as dry mouth, constipation, urinary retention, blurred vision and QT prolongation risk.

How serious is the interaction between Solifenacin and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic adverse effects and limit solifenacin to 5 mg daily if tucatinib is co-prescribed; consider an alternative agent in patients with QT risk.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in